1191911-27-9
中文名稱
CZC-54252
英文名稱
CZC-54252
CAS
1191911-27-9
分子式
C22H25ClN6O4S
分子量
504.99
MOL 文件
1191911-27-9.mol
更新日期
2026/07/20 08:35:49
1191911-27-9 結(jié)構(gòu)式
基本信息
中文別名
化合物CZC-54252N-(2-((5-氯-2-((2-甲氧基-4-嗎啉苯基)氨基)嘧啶-4-基)氨基)苯基)甲磺酸
英文別名
CS-1730CZC-54252
CZC-54252, >98%
CZC 54252
CZC54252
CZC 54252 hydrochloride
N-(2-(5-chloro-2-(2-methoxy-4-morpholinophenylamino)pyrimidin-4-ylamino)phenyl)methanesulfonamide
N-{2-[(5-chloro-2-{[2-methoxy-4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}methanesulfonamide
Methanesulfonamide, N-[2-[[5-chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-
N-[2-[[5-Chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide hydrochloride
所屬類別
生物化工：激動劑抑制劑物理化學(xué)性質(zhì)
沸點(diǎn)718.1±70.0 °C(Predicted)
密度1.452±0.06 g/cm3(Predicted)
儲存條件Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
溶解度DMF: 20 mg/mL; DMF:PBS(pH 7.2)(1:1): 0.5 mg/mL; DMSO: 10 mg/mL
酸度系數(shù)(pKa)8.50±0.10(Predicted)
形態(tài)粉末
顏色White to off-white
CZC-54252價格(試劑級)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/07/06 | S6534 | CZC-54252 CZC-54252 | 1191911-27-9 | 5mg | 794.45元 |
| 2026/06/05 | HY-B0792 | CZC-54252 | 1191911-27-9 | 5 mg | 720元 |
| 2026/06/05 | HY-B0792 | CZC-54252 CZC-54252 | 1191911-27-9 | 10mM * 1mLin DMSO | 800元 |
常見問題列表
生物活性
CZC-54252是一種有效的LRRK2抑制劑，對人源野生型LRRK2和G2019S LRRK2的IC50分別為1.28 nM和1.85 nM。靶點(diǎn)
| Target | Value |
|
LRRK2 (WT)
(Cell-free assay) | 1.28 nM |
|
LRRK2 (G2019S)
(Cell-free assay) | 1.85 nM |
體外研究
CZC-54252 inhibits the activity of recombinant human wild-type LRRK2 with an IC
50
ranging from ～1 to ～5 nM. The G2019S mutant is inhibited with an IC
50
ranging from ～2 to ～7 nM in a TF-FRET assay. In addition, they are screened against a kinase panel of 185 kinases and exhibited good selectivity.
G2019S LRRK2-induced human neuronal injury is attenuated by CZC-54252 with an EC
50
of ~1 nM and fully reversed to wild-type levels by CZC-54252 at concentration of 1.6 nM.